Abstract 4364194: Adverse Pregnancy Outcomes Are Associated with Incident Peripheral Artery Disease, Results from the Women’s Health Initiative.

E Elizabeth Jackson (University of Alabama at Birmingham, Birmingham, Alabama, United States) M Michael LaMonte (University at Buffalo - SUNY, Buffalo, New York, United States) K Kathleen Hovey (University at Buffalo - SUNY, Buffalo, New York, United States) C Chris Andrews (University of Buffalo, Buffalo, New York, United States) G Gretchen Wells (University of Kentucky, Lexington, Kentucky, United States) J JoAnn Manson (Brigham andWomen’s Hospital, Boston, MA, USA.) E Emily Levitan (UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States) C Cassandra Spracklen R Robert Wild (OU HEALTH SCIENCES CTR, Oklahoma City, Oklahoma, United States) E Erin LeBlanc (Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, United States) B Bernhard Haring L Laura Harrington (Kaiser Permanente Washington, Seattle, Washington, United States) M Matthew Allison C Charles Eaton (Harvard University, Cambridge, MA, USA.)

Abstract

Background: Women with a history of adverse pregnancy outcomes (APOs) have an increased risk for heart disease and stroke; however, data on risk for peripheral arterial disease (PAD) are scarce. Hypothesis: We hypothesized that women with a history of an APO were at greater risk for incident PAD. Methods: Data from the Women’s Health Initiative, which enrolled 161,808 postmenopausal women, aged 50-79 years, between 1993 and 1998, were used for the present analysis. Participants who completed survey items in 2017 on APO history were eligible for this study. Incident PAD was defined as ≥ one of the following in a lower extremity artery: stenosis or ulceration (≥50% diameter or ≥75% cross-sectional area) on imaging; absence of arterial pulse by Doppler; claudication on exercise testing; surgery, angioplasty or thrombolysis for PAD; amputation of or part of the lower extremity due to ischemia or gangrene; physician diagnosed claudication; or an ankle-brachial index (ABI) of ≤ 0.8. Events were adjudicated from baseline to 2010. Participants were eligible for this analysis if they did not have a history of PAD at baseline, had ≥1 pregnancy lasting > 6 months, and had non-missing data on APOs (n=47,370). Multivariable models examined the association between APOs and incident PAD, adjusting for age, race/ethnicity, education, income, physical activity, diet, sleep, and alcohol intake. Results: A history of APOs was reported by 13,666 women (28.8%), with 8,325 reporting one APO and 5,341 reporting two or more APOs. The most common APO reported was pre-term delivery (6,910 [14.6%]), followed by low birth weight (5,866 [12.4%]). Women who reported at least one APO had higher odds for incident PAD (adjusted odds ratio [aOR] 2.02, 95% confidence interval [CI] 1.43-2.85) compared to women without an APO. Individual APOs including gestational hypertension/preeclampsia (aOR 2.31, 95% CI 1.35-3.95), low birth weight (aOR 2.50, 95% CI 1.71-3.66), and preterm delivery (aOR 1.71, 95% CI 1.15-2.56) were associated with incident PAD, while gestational diabetes demonstrated a higher, but nonsignificant, odds for PAD (aOR 1.87, 95% CI 0.68-5.12). Conclusion: In this large cohort of multiethnic women, APOs were associated with a doubled risk for incident PAD. Gestational hypertension/preeclampsia, low birth weight, and preterm delivery were independently associated with incident PAD. Additional research is warranted to understand the underlying mechanisms linking APOs and PAD.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

E

Elizabeth Jackson

University of Alabama at Birmingham, Birmingham, Alabama, United States

M

Michael LaMonte

University at Buffalo - SUNY, Buffalo, New York, United States

K

Kathleen Hovey

University at Buffalo - SUNY, Buffalo, New York, United States

C

Chris Andrews

University of Buffalo, Buffalo, New York, United States

G

Gretchen Wells

University of Kentucky, Lexington, Kentucky, United States

J

JoAnn Manson

Brigham andWomen’s Hospital, Boston, MA, USA.

E

Emily Levitan

UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States

C

Cassandra Spracklen

R

Robert Wild

OU HEALTH SCIENCES CTR, Oklahoma City, Oklahoma, United States

E

Erin LeBlanc

Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, United States

B

Bernhard Haring

L

Laura Harrington

Kaiser Permanente Washington, Seattle, Washington, United States

M

Matthew Allison

C

Charles Eaton

Harvard University, Cambridge, MA, USA.